Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice

Publisher： John Wiley & Sons Inc

E-ISSN： 2471-254x|2|1|69-83

ISSN： 2471-254x

Source： Hepatology Communications, Vol.2, Iss.1, 2018-01, pp. : 69-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liraglutide for NASH/NAFLD

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 3, 2015-03 ,pp. : 269-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin Resistance, Non-alcoholic Fatty Liver Disease and Hepatitis C Virus Infection

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 204-209

Bentham Science Publishers

Access to resources Recommend Favorite

Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 944-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic inflexibility and insulin resistance in obese adolescents with non‐alcoholic fatty liver disease

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 3, 2015-05 ,pp. : 211-218

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E42-E51

John Wiley & Sons Inc

Access to resources Recommend Favorite